Diagnostic Value of 11C-Methionine PET-CT Imaging in Persistent or Recurrent Cushing Disease After Surgery
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf047 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Raluca Maria Furnica und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Cliniques Universitaires Saint-Luc UCL, 1200 Bruxelles, Belgium. Hauptthemen laut MEDLINE: Pituitary ACTH Hypersecretion, Positron Emission Tomography Computed Tomography, Methionine, ACTH-Secreting Pituitary Adenoma. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Doctoral Fellowship of the Belgian Fonds National de la Recherche Scientifique.
Abstract (Originalsprache)
Context
Equivocal or negative pituitary magnetic resonance imaging (MRI) findings pose a significant challenge in the management of persistent or recurrent Cushing disease (CD), compromising the chances of success of further transsphenoidal surgery (TSS).
Objective
To determine the diagnostic utility of 11C-methionine (11C-MET) positron emission tomography/computerized tomography (PET/CT) in localizing residual or relapsing corticotroph adenoma.
Methods
We retrospectively analyzed the results of all 11C-MET PET/CT performed at 2 tertiary medical centers between May 2002 and November 2023 in 22 patients with persistent/recurrent CD after initial TSS and equivocal/negative pituitary MRI. In 15 cases, 11C-MET PET/CT images were also co-registered with high-resolution 3D T1 or FLAIR MRI pituitary imaging.
Results
Of 22 patients (18 female; mean age 36 years at diagnosis; mean initial tumor maximum diameter 6.5 mm), 13 had a suspect anomaly on conventional MRI and 9 had a negative MRI. Maximal metabolic activity in the suspect area (SUVmaxT) was found in 14 patients (63.5%; 5/9 patients with negative pituitary MRI and 9/13 with equivocal findings). Based on positive imaging, 12 patients underwent repeat TSS, successful in 7, while 2 patients underwent Gamma Knife radiosurgery (GKRS), both resulting in remission (total remission rate of 64%). Among the 5 patients not cured by TSS, the presence of corticotroph adenoma in the resected tissue was found in 3 cases. Positive 11C-MET PET/CT had a detection rate accuracy of 86% (12/14). Of the 8 PET-negative patients, 2 underwent exploratory TSS, with no remission, and 2 underwent GKRS, with 1 long-term remission.
Conclusion
11C-MET PET/CT imaging can provide valuable diagnostic information to detect a corticotroph microadenoma in more than half of patients with persistent/recurrent CD and equivocal or negative MRI findings, allowing targeted TSS or radiosurgery with a global success rate of 64% in the selected subgroup with positive imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Nutrition, Cliniques Universitaires Saint-Luc UCL, 1200 Bruxelles, Belgium.
- Department of Endocrinology, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, 1070 Bruxelles, Belgium.
- Department of Nuclear Medicine and PET/Biomedical Cyclotron Unit, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), CUB Hôpital Erasme, 1070 Bruxelles, Belgium.
- Department of Endocrinology, Diabetology and Metabolism, University Antwerpen, 2650 Edegem, Belgium.
- Department of Nuclear Medicine, Cliniques Universitaires Saint-Luc UCL, 1200 Bruxelles, Belgium.
ORCID-Profile: Raluca Maria Furnica
Förderung
- Doctoral Fellowship of the Belgian Fonds National de la Recherche Scientifique
Zitieren
APA
Furnica, R. M., Devuyst, F., Mathey, C., Constantinescu, S. M., De Herdt, C., Alexopoulou, O., Lhommel, R., & Maiter, D. (2025). Diagnostic Value of 11C-Methionine PET-CT Imaging in Persistent or Recurrent Cushing Disease After Surgery. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf047
Vancouver
Furnica RM, Devuyst F, Mathey C, Constantinescu SM, De Herdt C, Alexopoulou O, et al. Diagnostic Value of 11C-Methionine PET-CT Imaging in Persistent or Recurrent Cushing Disease After Surgery. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf047
BibTeX
@article{Furnica2025,
author = {Furnica, Raluca Maria and Devuyst, France and Mathey, Céline and Constantinescu, Stefan Matei and De Herdt, Carlien and Alexopoulou, Orsalia and Lhommel, Renaud and Maiter, Dominique},
title = {Diagnostic Value of 11C-Methionine PET-CT Imaging in Persistent or Recurrent Cushing Disease After Surgery},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf047}
}
EUVIMED